Small Test Study: New Chinese Vaccine Increases Protection Against Covid-19

The vaccine, developed by Chinese researchers, was tested on more than 100 people and increased the number of antibodies that fight the virus causing Covid-19. Adverse reactions were common.

RIO DE JANEIRO, BRAZIL - Developed by Chinese researchers, a new Covid-19 vaccine project has yielded promising results reported in a study published in the prestigious The Lancet scientific journal. The vaccine was tested on 108 people, split into three groups, and produced a "significant" increase of antibodies against the novel coronavirus, according to the researchers.

The study is signed by 21 Chinese researchers and provides data on both safety and improved immunity against Covid-19, based on human patient testing. Most patients reported no severe reaction.

The number of antibodies against the novel coronavirus increased in the body of . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?